Carbiotix

Be the first to follow this company

Carbiotix is a biotechnology company active in the microbiome area. The company currently conducts research and development and sells products and services in primarily four business areas: Diagnosis of intestinal health, prebiotic ingredients, medical food and therapeutic treatments. The company was founded in 2014 and is headquartered in Lund.

ShowingAll content types

Press release12/20/2024, 1:00 PM

Impala Nordic: Carbiotix - Tillväxten av kundprojekt imponerar

Regulatory press release12/20/2024, 7:55 AM

Carbiotix provides Q4 2024 update of ongoing NutraCycle projects

Regulatory press release12/20/2024, 7:55 AM

Carbiotix ger uppdatering för Q4 2024 gällande pågående NutraCycle projekt

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account

Followings and notifications on followed companies

Analyst comments and recommendations

Stock comparison tool & other popular tools

Press release12/2/2024, 11:40 AM

Impala Nordic: Carbiotix - Analys: Fullt fokus på NutraCycle

Press release11/5/2024, 1:35 PM

Impala Nordic: Carbiotix - Rapportintervju med VD, Erik Deaner

Press release11/5/2024, 7:45 AM

Carbiotix AB offentliggör delårsrapport för Q3, 2024

Press release10/25/2024, 11:45 AM

Impala Nordic: Carbiotix - Impala Nordic initierar analysbevakning på Carbiotix

Press release9/30/2024, 1:15 PM

Carbiotix provides Q3 2024 update of ongoing NutraCycle projects

Press release9/30/2024, 1:15 PM

Carbiotix ger uppdatering för Q3 2024 gällande pågående NutraCycle projekt

Regulatory press release9/10/2024, 9:30 AM

Avstämningsdag för sammanläggning av aktier i Carbiotix AB (publ)

Regulatory press release8/29/2024, 8:15 PM

Carbiotix initierar åtta nya NutraCycle-förstudieprojekt och kommer att börja kvartalsrapportera om nya och pågående kundprojekt

Regulatory press release8/29/2024, 8:15 PM

Carbiotix initiates eight new NutraCycle pre-study projects and will begin quarterly reporting of new and ongoing customer projects

Regulatory press release8/26/2024, 1:00 PM

ISP lämnar anmälningar enligt UDI-lagen utan åtgärd och Carbiotix AB (publ) offentliggör utfall i riktad nyemission

Press release8/23/2024, 6:45 AM

Carbiotix slutför metforminstudie och ger uppdatering om EU-finansiering

Press release8/23/2024, 6:45 AM

Carbiotix completes metformin study and provides EU funding update

Regulatory press release8/20/2024, 11:30 AM

Carbiotix: Styrelseledamot avgår på egen begäran

Regulatory press release8/14/2024, 2:37 PM

Kommuniké från extra bolagsstämma i Carbiotix AB (publ)

Press release8/6/2024, 10:00 AM

Carbiotix AB offentliggör halvårsrapport, 2024

Press release7/8/2024, 9:30 AM

Kallelse till extra bolagsstämma i Carbiotix AB (publ)

Regulatory press release7/8/2024, 8:30 AM

The Board of Directors of Carbiotix AB (publ) proposes a directed share issue of a maximum of approximately SEK 7.00 million

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.